1. Health Survey for England 2010
www.ic.nhs.uk/pubs/hse10report (Accessed 23.05.12)
2. Scottish Health Survey 2010
www.scotland.gov.uk/News/Releases/2011/09/27102058 (Accessed 23.05.12)
3. Scottish Health Survey 2008
http://www.scotland.gov.uk/Publications/2009/09/28102003/0 (Accessed 23.05.12)
4. Scottish Intercollegiate Guidelines Network 1996. Obesity in Scotland: Integrating prevention with weight management. Edinburgh SIGN Guideline No 8
5. Torgerson JS, Hauptmann J,Boldrin MN, Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomised study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diab Care 2004; 27(1): 155-161
6. Tuomilehto J, Lindstom J, Eriksson et al. Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. NEJM 2001; 344(18): 1343-1350
7. Scottish Intercollegiate Guidelines Network 2010. Management of obesity No 115
http://www.sign.ac.uk/pdf/sign115.pdf (Accessed 23.05.12)
8. Lean MEJ. Management of obesity and overweight. Medicine 2011; 39: 32-38
9. Anderson JW, Kendall CW, Jenkins DJ. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr 2003; 22: 331-339
10. Dixon JB, O’Brien PE, Playfair J et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomised controlled trial. JAMA 2008; 23: 316-323
11. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122(3): 248-256
12. Lean MEJ, Powrie JK, Anderson AS, Garthwaite PH. Obesity, weight loss and prognosis in type 2 diabetes. Diab Med 1990; 7: 228-233
13. Schauer PR, Kashyap SR, Wolski K et al. Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes. N Engl J Med 2012; 366: 1567-1576
14. Lean MEJ, Finer N. Management: Part II – Drugs. ABC of Obesity. BMJ 2006; 333: 794-797
15. Franz MJ, VanWormer JJ, Crain AL et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007; 107: 1755-1767
16. Astrup A, Al Hakim M, Carraro R, Finer N et al. Sustained Weight Loss with Diet and Liraglutide for Obesity: A 52-week Dose-ranging Randomized. Int J Obesity 2011
17. Lean MEJ, Astrup A, Al Hakim M et al. Sustained weight-loss and acceptable tolerability with the GLP-1 analogue liraglutide in obese non-diabetic adults: a 2-year randomised trial. Obesity Reviews 2010 (Abstract)
18. Garrow, J. S. (1978). Energy balance and obesity in man, (2nd edn). Elsevier, Holland
19. Bliddal, H., Christensen, P., Riecke, B.F., Aaboe, J., Frederiksen, E., Bartels, E., Christensen, R. Osteoarthritis – a role for weight maintenance in rheumatology practice: an update. Clinical Obesity 2011; 1(1): 50-52
20. Lin WY, Wu CH, Chu NF et al. Efficacy and safety of very-low-calorie diet in Taiwanese: A multicentre randomised, controlled trial. Nutr 2009; 25:1129-1136
21. Christensen H, Bliddal BF, Riecke AR et al. Comparison of a low-energy diet and a very low-energy diet in sedentary obese individuals: a pragmatic randomised controlled trial. 2011; 31-40
22. National Obesity Forum, Position statement on the application of Very Low Energy Diets in achieving weight loss in the management of obesity
http://www.nationalobesityforum.org.uk/images/stories/_Final_version_NOF_consensus_statement_VLEDs.pdf (Accessed 23.05.12)
23. Lau S, Caterson ID. Meal replacement products and very low calorie diets in adult obesity. Bull RC Path 2011; 155: 172-174
24. Richelson B, Tonstad S, Rossner S et al. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients. Diab Care 2008; 299:316-323
25. Mathus-Vliegen EMH for the Balance Study Group. Long-term maintenance of weight-loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study. EJCN 2005; 59:S31-39
26. Apfelbaum M, Vague P, Ziegler O et al. Long-term maintenance of weight-loss after a very-low-calorie diet: a randomised blinded trial of the efficacy and tolerability of sibutramine. Am J Mec 1999; 106:179-184
27. The Counterweight Project Team. National implementation of the Counterweight Programme in Scotland, UK. Family Practice 2012; 29:i139-i144
28. SMID http://www.scotland.gov.uk/Topics/Statistics/SIMD (Accessed 23.05.12)
29. The Counterweight Project Team. Empowering primary care to tackle the obesity epidemic: the Counterweight Programme. Eur J Clin Nutr 2005; 59:S93-S101
30. Summerbell CD, Watts C, Higgins JPT, Garrow JS. Randomised controlled trial of novel, simple and well supervised weight reducing diets in outpatients. BMJ 1998; 317:1487-1489
31. Department of Health 2011
http://www.nhs.uk/Livewell/Goodfood/Pages/eatwell-plate.aspx (Accessed 23.05.12)
32. Schofield WN. Predicting Basal Metabolic Rate, new standards and review of previous work. Hum Nutr Clin Nutr 1985;44: 1-19
33. The Counterweight Project Team. A new evidence-based model for weight management in Primary Care: the Counterweight Programme. JHND 2004; 17: 191-208
34. Department of Health Department of Health, Physical Activity, Health Improvement and Protection 2011. Start Active, Stay Active: A report on physical activity from the four home countries’ Chief Medical Officers. London: Department of Health.
35. Source of unit costs: Personal Social Services Research Unit 2011 (PSSRU)
http://www.pssru.ac.uk/ (Accessed 23.05.12)
36. Source of costs: British National Formulary
http://www.bnf.org/bnf/index.htm
37. Wycherley TP, Mohr P, Noakes M, Clifton PM, et al. Self-reported facilitators of, and impediments to maintenance of healthy lifestyle behaviours following a supervised research-based lifestyle intervention programme in patients with type 2 diabetes. Diab Med 2012; 29: 632-639
38. Ackroyd R, Mouiel J, Chevallier JM, Daoud F. Cost-effectiveness and budget impact of obesity surgery in patients with type-2 diabetes in three European countries. Obes Surg 2006; 16(11): 1488-1503
39. Jolly K, Lewis A, Beach J et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight-loss in obesity: Lighten Up randomised controlled trial. BMJ 2011; 343: d6500
40. The Counterweight Project Team. Evaluation of the Counterweight Programme for obesity management in primary care: a starting point for continuous improvement. Br J Gen Pract 2008; 58:548-554
41. The Counterweight Project Team. Long-term cost effectiveness of weight management in Primary care. I J Clin Pract 2010; 64(6): 775-783
42. Johansson K, Hemmingsson E, Harlid R et al. Longer term effects of very low energy diet on obstructive sleep apnoea in cohort derived from randomised controlled trial: prospective observational follow-up study. BMJ 2011; 342: d3017
43. Bischoff SC, Damms-Machado A, Betz C et al. Multicenter evaluation of an interdisciplinary 52-week weight-loss program for obesity with regard to body weight, comorbidities and quality of life – a prospective study. IJO 2011; doi: 10.1038/ijo.2011.107 [Epub ahead of print]
44. Lean MEJ, Tigbe WW, Briggs et al. A patient-centre approach to estimate total annual healthcare costs by BMI in the UK Counterweight Programme. Obes Rev 2011; 12(S1) (Abstract)